About Lexaria Bioscience
Lexaria Bioscience is a company based in Kelowna (Canada) founded in 2004.. The company has 7 employees as of August 31, 2024. Lexaria Bioscience offers products and services including DehydraTECH. Lexaria Bioscience operates in a competitive market with competitors including Focus Financial Partners, Alera Group, Avidity Biosciences, Sutro Biopharma and Wintrust, among others.
- Headquarter Kelowna, Canada
- Employees 7 as on 31 Aug, 2024
- Stage Public
-
Sectors
HealthcareFinancial Services
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Lexaria Bioscience Corp.
-
Annual Revenue
$464.28 K105.24as on Aug 31, 2024
-
Net Profit
$-5.8 M13.05as on Aug 31, 2024
-
EBITDA
$-5.62 M12.04as on Aug 31, 2024
-
Latest Funding Round
$1.57 M (USD), Post-IPO
Oct 04, 2023
-
Investors
-
Employee Count
7
as on Aug 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Lexaria Bioscience
Lexaria Bioscience is a publicly listed company on the NASDAQ with ticker symbol LEXX in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Lexaria Bioscience
Lexaria Bioscience offers a comprehensive portfolio of products and services, including DehydraTECH. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Platform enhances absorption of oral pharmaceuticals and reduces side effects
Unlock access to complete
Unlock access to complete
Funding Insights of Lexaria Bioscience
- Total Funding Total Funding
- Total Rounds 16
- Last Round Post-IPO — $1.6M
-
First Round
First Round
(29 Dec 2009)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2023 | Amount | Post-IPO - Lexaria Bioscience | Valuation |
investors |
|
| Dec, 2021 | Amount | Post-IPO - Lexaria Bioscience | Valuation |
investors |
|
| Jul, 2020 | Amount | Post-IPO - Lexaria Bioscience | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Lexaria Bioscience
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Lexaria Bioscience
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Lexaria Bioscience Comparisons
Competitors of Lexaria Bioscience
Lexaria Bioscience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Focus Financial Partners, Alera Group, Avidity Biosciences, Sutro Biopharma and Wintrust, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Business consulting services are provided to banks and lending institutions.
|
|
| domain | founded_year | HQ Location |
HR, insurance, and liability services are provided by Alera Group.
|
|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| domain | founded_year | HQ Location |
Bank offering diversified financial services
|
|
| domain | founded_year | HQ Location |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Lexaria Bioscience
Frequently Asked Questions about Lexaria Bioscience
When was Lexaria Bioscience founded?
Lexaria Bioscience was founded in 2004 and raised its 1st funding round 5 years after it was founded.
Where is Lexaria Bioscience located?
Lexaria Bioscience is headquartered in Kelowna, Canada. It is registered at Kelowna, British Columbia, Canada.
Who is the current CEO of Lexaria Bioscience?
Chris Bunka is the current CEO of Lexaria Bioscience.
How many employees does Lexaria Bioscience have?
As of Aug 31, 2024, the latest employee count at Lexaria Bioscience is 7.
What is the annual revenue of Lexaria Bioscience?
Annual revenue of Lexaria Bioscience is $464.28K as on Aug 31, 2024.
What does Lexaria Bioscience do?
Lexaria Bioscience was founded in 2004 in Kelowna, Canada, within the biotechnology sector. Patented DehydraTECH technology is utilized for delivering fat-soluble active molecules and drugs, encompassing nicotine, NSAID pain-relievers, and other bioactives. Operations focus on formulation and delivery methods, with topical products such as patches, creams, and lotions also developed for administration.
Who are the top competitors of Lexaria Bioscience?
Lexaria Bioscience's top competitors include Sutro Biopharma, Focus Financial Partners and Alera Group.
What products or services does Lexaria Bioscience offer?
Lexaria Bioscience offers DehydraTECH.
Is Lexaria Bioscience publicly traded?
Yes, Lexaria Bioscience is publicly traded on NASDAQ under the ticker symbol LEXX.
What is Lexaria Bioscience's ticker symbol?
The ticker symbol of Lexaria Bioscience is LEXX on NASDAQ.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.